INVO Bioscience (INVO)
NASDAQ:INVO
US Market
Holding INVO?
Track your performance easily

INVO Bioscience (INVO) Financial Statements

132 Followers

INVO Bioscience Financial Overview

INVO Bioscience's market cap is currently ―. The company's EPS TTM is $-2.544; its P/E ratio is -0.27; INVO Bioscience is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.84M$ 1.58M$ 1.38M$ 974.89K$ 254.36K
Gross Profit$ 974.95K$ 726.05K$ 495.00K$ 393.93K$ 315.90K
EBIT$ -2.25M$ -1.41M$ -1.79M$ -894.47K$ -2.06M
EBITDA$ -1.76M$ -1.19M$ -1.65M$ -873.97K$ -1.98M
Net Income Common Stockholders$ -2.25M$ -1.60M$ -1.99M$ -1.25M$ -2.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 942.93K$ 475.13K$ 232.42K$ 1.06M$ 112.48K
Total Assets$ 18.03M$ 18.32M$ 20.89M$ 19.48M$ 6.64M
Total Debt$ 3.92M$ 4.70M$ 7.17M$ 7.10M$ 4.10M
Net Debt$ 2.97M$ 4.23M$ 6.94M$ 6.05M$ 3.99M
Total Liabilities$ 16.67M$ 18.31M$ 18.49M$ 19.10M$ 8.34M
Stockholders Equity$ 1.36M$ 10.15K$ 892.83K$ 372.80K$ -1.71M
Cash Flow-
Free Cash Flow$ -1.46M$ -284.67K$ -789.88K$ -1.36M$ -1.91M
Operating Cash Flow$ -1.46M$ -260.56K$ -714.88K$ -1.25M$ -1.64M
Investing Cash Flow$ -5.13K$ -24.11K$ 33.29K$ -2.26M$ -261.50K
Financing Cash Flow$ 1.93M$ 527.37K$ -141.53K$ 4.45M$ -169.86K
Currency in USD

INVO Bioscience Earnings and Revenue History

INVO Bioscience Debt to Assets

INVO Bioscience Cash Flow

INVO Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis